We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Jonathan Chrispin

Jonathan Chrispin MD

Robert E. Meyerhoff Assistant Professor of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland

Dr. Jonathan Chrispin is the Robert E. Meyerhoff Assistant Professor of Medicine in the Division of Cardiology and Co-Director of the Ventricular Arrhythmia Ablation Program at the Johns Hopkins University School of Medicine. He is a graduate of Harvard College in Cambridge, MA, followed by an MD degree as a Dean’s scholar from Vanderbilt University School of Medicine in Nashville, TN. He completed his training in Internal Medicine, Cardiovascular Disease, and Clinical Electrophysiology at the Johns Hopkins University School of Medicine, where he served as the Chief Fellow. His clinical focus is on managing complex atrial and ventricular arrhythmias through medical therapy, implantable cardiac device therapy, and catheter ablation. As Director of the Ventricular Arrhythmia Research Program, Dr. Chrispin’s research has focused on using advanced imaging to understand better the structural and electrical substrates associated with the development of ventricular arrhythmias. In addition, in collaboration with the Johns Hopkins Biomedical Engineering department, he has worked to develop machine learning algorithms to combine cardiac imaging, ambulatory mobile electrocardiogram data, and computational modeling to predict the risk of sudden cardiac death and further guide catheter ablation of ventricular arrhythmias.

Disclosures

Dr. Chrispin reports the following:
  • Consulting- Biosense Webster, Abbott
  • Reviewer- Elsevier Clinical Overviews